Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Takeda Cambridge, Dimerix In Second GPCR Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Takeda Cambridge, Dimerix In Second GPCR Pact

Dimerix Bioscience Pty Ltd. has entered into a second research program with Takeda Cambridge Ltd., a UK based subsidiary of Takeda Pharmaceutical Co.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Dimerix Bioscience Pty Ltd. has entered into a second research program with Takeda Cambridge Ltd., a UK based subsidiary of Takeda Pharmaceutical Co. This new program is in addition to the companies’ April 2010 research collaboration.

Dimerix is a preclinical stage company developing a pipeline of lead products with highly specific activity and reduced risk of off-target effects. Under the new agreement, Dimerix will continue to use its GPCR-HIT platform and G Protein-Coupled Receptors (GPCRs) expertise to form complexes to work with additional undisclosed Takeda targets.

Mark Carlton, president of Takeda Cambridge Ltd. said: “We are impressed by Dimerix’s achievements over the last 12 months and with the depth of information we have obtained by accessing the power of their GPCR-HIT platform. We have seen that the insights generated using GPCR-HIT provide us with an important extension to our GPCR drug discovery efforts. We are very pleased to be able to expand our efforts with Dimerix.”

Tim Grogan, chief executive officer of Dimerix, said: “We are very pleased with this further expansion of our relationship with Takeda Cambridge. The relevance of our GPCR-HIT platform to the drug discovery and development process and our insights into the formation of complexes between G Protein-Coupled Receptors have been recognized again through this partnership with Takeda Cambridge.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics